‹ All stocks
Drugs Made In America Acquisition II Corp. Ordinary Shares
DMII · NASDAQ · Financial Services
$10.20
▲ $10.20 (0.14%)
Day range
$10.19 – $10.20
Year range
$9.86 – $10.33
Open
$10.19
Previous close
—
Market cap
$649.74M
Volume (24h)
$14.1K
Volume (52w)
$143.73K
Performance
7D
▲ 0.29%
1M
▲ 0.29%
3M
▲ 1.09%
6M
▲ 2.20%
1Y
▲ 3.24%
YTD
▲ 3.03%
3Y
▲ 3.24%
5Y
▲ 3.24%
All-time
▲ 3.24%
Key statistics
P/E ratio
—
EPS (TTM)
—
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
63.7M
About Drugs Made In America Acquisition II Corp. Ordinary Shares
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
Visit websiteCountry: United States of America
More in Financial Services
BRK-B Berkshire Hathaway |
$500.52 | 0.08% |
JPM JPMorgan Chase & Co. |
$330.92 | -0.92% |
V Visa |
$359.82 | -0.11% |
MA Mastercard Incorporated |
$551.37 | 0.01% |
BAC Bank of America |
$53.63 | -0.49% |